Liquidia (LQDA) Gross Margin (2020 - 2026)
Liquidia's (LQDA) quarterly Gross Margin came in at 91.66% in Q1 2026, up 4028.0% year-on-year from 2.22% in Q1 2025, and down 2.92% quarter-over-quarter from 94.42% in Q4 2025.
Liquidia (LQDA) Gross Margin (2020 - 2026) Analysis & Trends
Liquidia's Gross Margin history runs 7 years deep, the most recent figure standing at 91.66% for Q1 2026.
- On a quarterly basis, Gross Margin rose 4028.0% year-over-year to 91.66% in Q1 2026; TTM through Mar 2026 was 93.13%, a 3504.0% increase from a year earlier, with the FY2025 full-year figure at 94.43%, up 3643.0% from the prior year.
- Gross Margin slipped to 91.66% in Q1 2026 per LQDA's latest filing, from 94.42% in the prior quarter.
- Across five years, Gross Margin topped out at 95.78% in Q3 2025 and bottomed at 50.64% in Q1 2024.
- The 5-year median for Gross Margin is 81.34% (2022), against an average of 76.82%.
- Across the five-year window, Gross Margin sank 3480 bps in 2024 and jumped 4084 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 87.05% in 2022, then decreased by 10 bps to 78.08% in 2023, then plunged by 31 bps to 53.58% in 2024, then surged by 76 bps to 94.42% in 2025, then dropped by 3 bps to 91.66% in 2026.
- Per Business Quant, the three latest LQDA Gross Margin figures stand at 91.66% (Q1 2026), 94.42% (Q4 2025), and 95.78% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 91.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.66% |
| Dec 31, 2025 | 94.42% |
| Sep 30, 2025 | 95.78% |
| Jun 30, 2025 | 85.38% |
| Mar 31, 2025 | 51.38% |
| Dec 31, 2024 | 53.58% |
| Sep 30, 2024 | 64.82% |
| Jun 30, 2024 | 59.20% |
| Mar 31, 2024 | 50.64% |
| Dec 31, 2023 | 78.08% |
| Sep 30, 2023 | 84.50% |
| Jun 30, 2023 | 85.98% |
| Mar 31, 2023 | 85.44% |
| Dec 31, 2022 | 87.05% |
| Sep 30, 2022 | 76.62% |
| Jun 30, 2022 | 81.34% |
| Mar 31, 2022 | 80.13% |
| Dec 31, 2021 | 77.42% |
| Sep 30, 2021 | 72.00% |
| Jun 30, 2021 | 78.85% |